The medication works by enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, and slowing gastric emptying, which collectively improve glycemic control and promote weight loss
Key GLP-1 Receptor Agonist Cardiovascular Outcome Trials Why Do GLP-1 Medications Protect the Heart
A Shift in How We Think About Osteoarthritis For a long time, osteoarthritis has been described as a wear-and-tear condition
The effects of bariatric surgery on cardiovascular outcomes and cardiovascular mortality: A systematic review and meta-analysis
Its only a 20-minute jog there and back, and after 10 minutes I get a reward I take a picture of the pond so I can stitch together a gallery of the changing seasons at the end of the year
Reviewed by: FormBlends Medical Team | Last updated: May 29, 2026 | Sources: USP general chapters, FDA compounding guidance, peer-reviewed GLP-1/GIP pharmacology literature, manufacturer prescribing information